| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNASEK-C17ORF49 | Coxsackie virus B3 (CG strain of CVB3) | MOI = 0.5 ;
23 hr |
HeLa Human papillomavirus-related endocervical adenocarcinoma cells | Microarray | 0.477406271 | Downregulation | 0.000154 | GeneSpring GX v11.5.1 software package (Agilent Technologies) | student's t test | 2019 | 31388922 |
| RNASEK-C17orf49 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 2.344369543 | Upregulation | 0 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose